Evidence map›Paper›PMID 37139087›Full record

ArticleFrontiers in aging neuroscience2023

SNP rs3803264 polymorphisms in

Changying Chen, Xincheng Gu, Fangyuan Liu, Congyong Sun, Jialin Mu, Defu Jin, Xuemei Sui, Deqin Geng, Qingqing Li, Yuzhang Jiang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Changying ChenDepartment of Epidemiology, Center of Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Xincheng GuDepartment of Epidemiology, Center of Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Fangyuan LiuDepartment of Epidemiology, Center of Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Congyong SunDepartment of Medical Laboratory, Huai'an First People's Hospital, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Jialin MuDepartment of Epidemiology, Center of Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Defu JinDepartment of Medical Laboratory, Huai'an First People's Hospital, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Xuemei SuiDepartment of Medical Laboratory, Huai'an First People's Hospital, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Deqin GengDepartment of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Qingqing LiDepartment of Neurology, The Third People's Hospital of Xuzhou, Xuzhou, Jiangsu, China.
Yuzhang JiangDepartment of Medical Laboratory, Huai'an First People's Hospital, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Chong ShenDepartment of Epidemiology, Center of Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Nanjing Medical University · CNSecond People’s Hospital of Huai’an · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thrombospondin Type 1 Domain Containing Protein 1 (THSD1) has been suggested to be a new regulator of endothelial barrier function in the angiogenesis process, preserving vascular integrity. We sought to characterize the association of Methods: A case-control study was conducted with 843 HS cases and 1,400 healthy controls. A cohort study enrolled 4,080 participants free of stroke at baseline in 2009 and followed up to 2022. A synonymous variant, the main tag SNP rs3803264 of the Results: In the case-control study, rs3803264 AG/GG variations are associated with a decreased risk of HS with odd ratio ( Conclusion: SNP rs3803264 polymorphisms in

Indexed as

case–control studyhemorrhagic strokemRNA expressionsingle nucleotide polymorphismsthrombospondin type 1 domain containing 1

Identifiers

PMID37139087
PMCPMC10150931
OpenAlexW4366158508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.